World-leading life sciences cluster

Dense network of universities, corporates, start-ups and service providers

More than 160 biotech companies, among them a lot of start-ups, are developing therapeutics in Switzerland, which puts Switzerland in the same league as much larger countries, such as Germany and France. This strength can lead to spectacular success; for example, in 2017 Johnson & Johnson acquired Actelion, founded in 1997, for USD 30 billion. Switzerland also has great strength in the medtech sector, with the highest density of medtech companies in Europe.

By continuing to use this website you agree with our TERMS AND CONDITIONS